This website uses cookies to ensure you get the best experience on the website.If you continue to browse, then you agree to our Cookie Policy and Privacy Policy.
Clinical ink is leading the way to recenter decentralized clinical trials by connecting data and operations. At the core of our clinical trial solutions is the Clinical ink eSource ecosystem, designed to ingest all incoming data into a unified data platform that supports analytics within and across studies, regardless of how it was captured or by whom. Our eSource methods integrate Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) for a wide range of phases and therapeutic areas. The result is faster, higher-quality clinical trial data. Our eSource solutions ingest data from multiple sources, facilitating decentralized trials and shifting the industry towards capturing data directly from the patient.
In this informative webinar, discover strategies for patient engagement and digital therapeutics relating to the management of social determinants of health in cardiometabolic diseases and recent Food and Drug Administration (FDA) guidance on the future of Lupus research.